Becton Dickinson projects $950 mil. in annual Injection Systems sales by 1999.
This article was originally published in The Gray Sheet
Executive SummaryBECTON DICKINSON INJECTION SYSTEMS SALES PROJECTED TO HIT $950 MIL. BY 1999, Gary Cohen, president of BD's Worldwide Injection Systems business, told analysts July 25 in New York City. As the unit increases its focus on the safety and pre-filled product segments and expands into new geographic areas, BD anticipates it will post a 10% annual compound revenue growth rate until 1999, Cohen said.
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.